Extensions

Analysis of Patent Term, Continuity, and Family for US Patent 11,798,576

An analysis of the public records for US Patent 11,798,576 provides the following details regarding its term, application history, and related patents.

Patent Term and Expiration:

• Patent Term Adjustment (PTA): There is no record of any Patent Term Adjustment (PTA) for US Patent 11,798,576. The patent's term is the standard 20 years from its earliest non-provisional filing date.
• Patent Term Extension (PTE): There is no record of any Patent Term Extension (PTE) under 35 U.S.C. § 156, which typically applies to delays in regulatory review for products like pharmaceuticals and medical devices.
• Projected Expiration Date: The application for this patent (16/671,830) was filed on November 1, 2019. It claims priority to an earlier PCT application filed on February 27, 2014. The 20-year patent term is calculated from this earliest priority date. Therefore, the projected expiration date for US Patent 11,798,576 is February 27, 2034.

Continuity and Application History:

• Continuation Application: US Patent 11,798,576 issued from application number 16/671,830, which is a continuation of U.S. application Ser. No. 15/115,804, filed on August 1, 2016 (now abandoned).
• Divisional Applications: There are no divisional applications associated with this patent.

Patent Family:

US Patent 11,798,576 is part of a larger patent family, sharing a common priority claim. This family includes:

• U.S. Application 15/115,804: The parent application, filed August 1, 2016, which is now abandoned. Its publication number is US 2017/0011753 A1.
• PCT Application PCT/US2014/018905: The international application filed on February 27, 2014, from which the U.S. applications claim priority. Its publication number is WO 2015/130283 A1.
• European Patent EP3103204B1: A granted European patent that is also a member of this family.